These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15253703)

  • 1. Regulation of intestinal epithelial gene expression in hypoxia.
    Taylor CT
    Kidney Int; 2004 Aug; 66(2):528-31. PubMed ID: 15253703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
    Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
    J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.
    Synnestvedt K; Furuta GT; Comerford KM; Louis N; Karhausen J; Eltzschig HK; Hansen KR; Thompson LF; Colgan SP
    J Clin Invest; 2002 Oct; 110(7):993-1002. PubMed ID: 12370277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of hypoxia on mucosal barrier function.
    Karhausen J; Ibla JC; Colgan SP
    Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):77-87. PubMed ID: 12839339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier.
    Boivin MA; Ye D; Kennedy JC; Al-Sadi R; Shepela C; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G590-8. PubMed ID: 17068119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6.
    Sitaraman SV; Merlin D; Wang L; Wong M; Gewirtz AT; Si-Tahar M; Madara JL
    J Clin Invest; 2001 Apr; 107(7):861-9. PubMed ID: 11285305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine tumor necrosis factor alpha induces intestinal epithelial barrier dysfunction.
    Wang QY; Sun AM; Song J; Chen Y; Wang JD; Li CG
    Cytokine; 2012 May; 58(2):226-30. PubMed ID: 22341723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model.
    Kono T; Kaneko A; Hira Y; Suzuki T; Chisato N; Ohtake N; Miura N; Watanabe T
    J Crohns Colitis; 2010 Jun; 4(2):161-70. PubMed ID: 21122500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines.
    Amasheh M; Grotjohann I; Amasheh S; Fromm A; Söderholm JD; Zeitz M; Fromm M; Schulzke JD
    Scand J Gastroenterol; 2009; 44(10):1226-35. PubMed ID: 19658020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation.
    Leppkes M; Roulis M; Neurath MF; Kollias G; Becker C
    Int Immunol; 2014 Sep; 26(9):509-15. PubMed ID: 24821262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo.
    Clayburgh DR; Musch MW; Leitges M; Fu YX; Turner JR
    J Clin Invest; 2006 Oct; 116(10):2682-94. PubMed ID: 17016558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial tight junctions in intestinal inflammation.
    Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
    Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.
    Tursi A; Elisei W; Principi M; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E; Brandimarte G
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):261-5. PubMed ID: 25267953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.
    Shkoda A; Ruiz PA; Daniel H; Kim SC; Rogler G; Sartor RB; Haller D
    Gastroenterology; 2007 Jan; 132(1):190-207. PubMed ID: 17241871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
    Renner M; Bergmann G; Krebs I; End C; Lyer S; Hilberg F; Helmke B; Gassler N; Autschbach F; Bikker F; Strobel-Freidekind O; Gronert-Sum S; Benner A; Blaich S; Wittig R; Hudler M; Ligtenberg AJ; Madsen J; Holmskov U; Annese V; Latiano A; Schirmacher P; Amerongen AV; D'Amato M; Kioschis P; Hafner M; Poustka A; Mollenhauer J
    Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular zinc is required for intestinal cell survival signals triggered by the inflammatory cytokine TNFα.
    Ranaldi G; Ferruzza S; Canali R; Leoni G; Zalewski PD; Sambuy Y; Perozzi G; Murgia C
    J Nutr Biochem; 2013 Jun; 24(6):967-76. PubMed ID: 22967671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.
    Söderholm JD; Streutker C; Yang PC; Paterson C; Singh PK; McKay DM; Sherman PM; Croitoru K; Perdue MH
    Gut; 2004 Dec; 53(12):1817-24. PubMed ID: 15542521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.
    Sanders DS
    J Clin Pathol; 2005 Jun; 58(6):568-72. PubMed ID: 15917403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.